Sjögren's disease & overlap diseases

Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B

Ann Rheum DisPublished Case-control study

Authors' conclusion

We identified antigenic targets of the autoantibody response in SS that may be useful for identifying up to half of Ro seronegative SS cases.

Study context

Population
Primary Sjögren's syndrome, including anti-Ro/SS-A negative cases; discovery dataset n=30 Sjögren's syndrome (SS), n=15 HC; independent rheumatology practice cohort n=38 Ro+, n=36 Ro-, n=10 HCvalidation dataset
Participants
46 / 50 / 42 / 54
Comparison
SS vs healthy and other disease controls
  • Ro+ SSn = 46
  • Ro- SSn = 50
  • HCn = 42reference
  • Other disease (OD)n = 54
Outcome
Autoantibodies identifying anti-Ro/SS-A negative primary SS
Methodological detailsproof-of-concept, discovery and validation datasets, random forest machine learning
  • Proof-of-concept
  • Discovery and validation datasets
  • Random forest machine learning

Main finding

As reported in the abstract

Binding to ≥1 of the novel antigens
GroupValueSpecificity
Ro- SS54%100%
Ro+ SS37%100%

Value

Ro- SS54%
Ro+ SS37%

Specificity

Ro- SS100%
Ro+ SS100%
Novel autoantibody specificities in SS plasma
12
Novel specificities detected in both discovery and validation datasets
11

Observational data: associations, not effects.

Further findings

OutcomeValues
Machine learning (30 novel specificities) for identifying Ro- SSRo- SS AUC 0.79 (95% CI 0.64 to 0.93)

Independent cohort: non-canonical antigens bound by Ro- sera

Non-canonical antigens bound by sera from Ro- cases
17

Ro+ SS parotid saliva autoantibodies

Bound Ro60, Ro52, La/SS-B and muscarinic receptor 5

Original publication

Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B. Ann Rheum Dis. Published 5 May 2023. doi:10.1136/ard-2022-223105

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.